Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2026-01-01 @ 6:07 AM
Study NCT ID:
NCT03164603
Status:
COMPLETED
Last Update Posted:
2020-06-04
First Post:
2017-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NLG802 Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors
Sponsor:
NewLink Genetics Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-25
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-22
First Submit QC Date:
None
Study First Post Date:
2017-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-03
Last Update Post Date:
2020-06-04
Last Update Post Date Type:
ACTUAL